BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15341262)

  • 1. [Contemporary diagnostic criteria for polycystic ovary syndrome].
    Pekhlivanov B; Mitkov M
    Akush Ginekol (Sofiia); 2004; 43(3):55-8. PubMed ID: 15341262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic ovarian syndrome--an update on diagnostic evaluation.
    Carmina E
    J Indian Med Assoc; 1999 Feb; 97(2):41-2. PubMed ID: 10549191
    [No Abstract]   [Full Text] [Related]  

  • 3. Estrogenic ovulatory dysfunction or functional female hyperandrogenism: an argument to discard the term polycystic ovary syndrome.
    Behera M; Price T; Walmer D
    Fertil Steril; 2006 Nov; 86(5):1292-5. PubMed ID: 17070182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research.
    Barth JH; Yasmin E; Balen AH
    Clin Endocrinol (Oxf); 2007 Dec; 67(6):811-5. PubMed ID: 17760885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostics of polycystic ovary syndrome].
    Lazúrová I; Figurová J; Lazúrová Z
    Vnitr Lek; 2015 Dec; 61(12 Suppl 5):5S40-4. PubMed ID: 27124971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovary syndrome/hyperandrogenic chronic anovulation.
    Lobo RA
    Adv Endocrinol Metab; 1995; 6():167-91. PubMed ID: 7671095
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrinological markers for assessing hyperandrogenemia in women classified as having polycystic ovary syndrome (PCOS) according to the revised 2003 diagnostic criteria.
    Mueller A; Dittrich R; Binder H; Hoffmann I; Beckmann MW; Cupisti S
    Eur J Med Res; 2006 Dec; 11(12):540-4. PubMed ID: 17182367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of laparoscopic ovarian diathermy on circulating inhibin B in women with anovulatory polycystic ovary syndrome.
    Hendriks ML; Lambalk CB
    Hum Reprod; 2007 Jul; 22(7):2073; author reply 2073-4. PubMed ID: 17525068
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis, phenotype, and prevalence of polycystic ovary syndrome.
    Carmina E; Azziz R
    Fertil Steril; 2006 Jul; 86 Suppl 1():S7-8. PubMed ID: 16798288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovary syndrome: definitions, phenotypes and diagnostic approach.
    Livadas S; Diamanti-Kandarakis E
    Front Horm Res; 2013; 40():1-21. PubMed ID: 24002401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors.
    Broekmans FJ; Knauff EA; Valkenburg O; Laven JS; Eijkemans MJ; Fauser BC
    BJOG; 2006 Oct; 113(10):1210-7. PubMed ID: 16972863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic criteria of polycystic ovary syndrome].
    Mori T
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Apr; 36(4):637-42. PubMed ID: 6715945
    [No Abstract]   [Full Text] [Related]  

  • 15. Androgen circle of polycystic ovary syndrome.
    Homburg R
    Hum Reprod; 2009 Jul; 24(7):1548-55. PubMed ID: 19279033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome.
    Hart R; Hickey M; Franks S
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):671-83. PubMed ID: 15380140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines.
    Carmina E
    Minerva Ginecol; 2004 Feb; 56(1):1-6. PubMed ID: 14973405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiometabolic abnormalities in the polycystic ovary syndrome: pharmacotherapeutic insights.
    Westerveld HE; Hoogendoorn M; de Jong AW; Goverde AJ; Fauser BC; Dallinga-Thie GM
    Pharmacol Ther; 2008 Sep; 119(3):223-41. PubMed ID: 18602948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical inquiries. What is the best way to diagnose polycystic ovarian syndrome?
    Meurer LN; Kroll AP; Jamieson B; Yousefi P
    J Fam Pract; 2006 Apr; 55(4):351-2, 354. PubMed ID: 16608676
    [No Abstract]   [Full Text] [Related]  

  • 20. The diagnosis of polycystic ovary syndrome in adolescents.
    Carmina E; Oberfield SE; Lobo RA
    Am J Obstet Gynecol; 2010 Sep; 203(3):201.e1-5. PubMed ID: 20435290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.